Allogene Therapeutics, Inc. · NASDAQ:ALLO

Allogene Therapeutics, Inc. shareholders

As of Sep 30, 2026, 192 institutions reported holding Allogene Therapeutics, Inc., 87.7% of its shares. Largest: BlackRock, Citadel and Frazier Life Sciences Management, L.P. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Allogene Therapeutics, Inc.ChangeFiled
BlackRock30.9M8.9%+780KNov 13, 2026
Citadel24.6M7.1%+14.5MNov 16, 2026
Frazier Life Sciences Management, L.P.22.4M6.5%no changeNov 16, 2026
Pfizer Inc22M6.4%no changeNov 12, 2026
Vanguard17.9M5.2%−618KNov 16, 2026
State Street16.3M4.7%−2.7MNov 12, 2026
Primecap Management Co13.1M3.8%+23,400Nov 12, 2026
UBS10.7M3.1%+7.67MNov 10, 2026
Fidelity10.6M3.1%−1.41MNov 10, 2026
Sio Capital Management, LLC9.1M2.6%−4.22MNov 16, 2026

Allogene Therapeutics, Inc. insider trades